Conditions

The FDA approved the 90-day version of the implantable CGM Sensor.

A dual-hormone, artificial pancreas delivering rapid insulin and the drug pramlintide improved glucose management and reduced glucose variability in adults with type 1 compared to an insulin-only, first-generation artificial pancreas.

The natural history of T2DM has been well described in multiple populations and is reviewed in references [1] and [3]. Individuals destined to develop T2DM inherit a set of genes from their parents that make their tissues resistant to insulin and the insulin resistance is aggravated by weight gain and physical inactivity. Hepatic insulin resistance is manifested by an overproduction of glucose during the basal state despite the presence of fasting hyperinsulinemia [38] and an impaired suppression of hepatic glucose production (HGP)

In part 2 of this Exclusive Interview, Dr. Scott Kahan shares tips for medical professionals without an expertise in nutrition and obesity during a discussion with Diabetes in Control Associate Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA.

In part 3 of this Exclusive Interview, Dr. Scott Kahan talks with Diabetes in Control Associate Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about the differences between what is consumed and genetics as they impact health outcomes.

In part 4 of this Exclusive Interview, Dr. Scott Kahan talks with Diabetes in Control Associate Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about the various factors that complicate weight management and the need to reduce blame and increase support.

In part 5 of this Exclusive Interview, Dr. Scott Kahan talks with Diabetes in Control Associate Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about his preference to ask permission of the patient to talk about their weight and the importance of having a compassionate discussion.

In part 6, the conclusion of this Exclusive Interview, Dr. Scott Kahan talks with Diabetes in Control Associate Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about the stigma and impact of having excess weight.

Mini-dose glucagon might be a better option for treating exercise-induced hypoglycemia than carbohydrate ingestion or insulin dose reduction.

Study describes patient characteristics that place patients with type 2 diabetes at increased risk for severe hypoglycemia.